Natus Medical Inc
NTUS
NTUS was delisted on the 20th of July, 2022.
172 hedge funds and large institutions have $753M invested in Natus Medical Inc in 2021 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 61 increasing their positions, 65 reducing their positions, and 10 closing their positions.
2,533% more call options, than puts
Call options by funds: $237K | Put options by funds: $9K
60% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 10
2% more funds holding
Funds holding: 169 → 172 (+3)
6% less repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 65
5% less capital invested
Capital invested by funds: $794M → $753M (-$40.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$3.39M |
| 2 |
BlackRock
New York
|
+$3.13M |
| 3 |
JP Morgan Chase
New York
|
+$2.98M |
| 4 |
TCM
Tributary Capital Management
Omaha,
Nebraska
|
+$2.8M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$2.34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$41.3M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$8.39M |
| 3 |
Prudential Financial
Newark,
New Jersey
|
-$2.34M |
| 4 |
Goldman Sachs
New York
|
-$1.81M |
| 5 |
Diamond Hill Capital Management
Columbus,
Ohio
|
-$1.74M |
NTUS Hedge Fund Activity: Q4 2021 in Review
172 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q4 2021, worth a combined $753M — down 5.1% from $794M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new NTUS positions and 10 closed out — a net gain of 6 holders — while 61 added to existing stakes and 65 trimmed.
The largest buyer was Victory Capital Management, adding an estimated $3.39M. The largest seller was Wells Fargo, cutting an estimated $41.3M.
- 172 institutional investors held Natus Medical Inc (NTUS) as of Q4 2021, up from 169 in Q3 2021.
- Funds reported $753M of Natus Medical Inc stock for Q4 2021, down 5.1% quarter-over-quarter.
- 16 funds opened new Natus Medical Inc positions in Q4 2021 and 10 closed out, a net change of +6 holders.
- The largest Natus Medical Inc buyer in Q4 2021 was Victory Capital Management, an estimated $3.39M added.
- The largest Natus Medical Inc seller in Q4 2021 was Wells Fargo, an estimated $41.3M sold.
Based on aggregated 13F filings for Q4 2021.